# Neuromolecular Risk Factors for Obesity (PROSPECT)

> **NCT03106688** · NA · UNKNOWN · sponsor: **Turku University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DIAGNOSTIC_TEST:** fMRI imaging
- **DIAGNOSTIC_TEST:** [11C]carfentanil PET scan
- **DIAGNOSTIC_TEST:** [18F]FMPEP-d2 PET scan
- **DIAGNOSTIC_TEST:** [18F]-FDG PET scan
- **DIAGNOSTIC_TEST:** Physical activity measures and fitness tests
- **DIAGNOSTIC_TEST:** Laboratory measurements
- **DIAGNOSTIC_TEST:** Questionnaires
- **DIAGNOSTIC_TEST:** Hyperinsulinemic euglycemic clamp

## Key facts

- **NCT ID:** NCT03106688
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-04
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03106688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03106688, "Neuromolecular Risk Factors for Obesity (PROSPECT)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03106688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*